| Product Code: ETC12463531 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Imatinib Drug Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Imatinib Drug Market - Industry Life Cycle |
3.4 Sweden Imatinib Drug Market - Porter's Five Forces |
3.5 Sweden Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Sweden Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Sweden Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Sweden Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Sweden Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Sweden |
4.2.2 Growing awareness about the benefits of imatinib drug therapy |
4.2.3 Favorable government policies and regulations supporting access to imatinib treatment |
4.3 Market Restraints |
4.3.1 High cost of imatinib drug leading to affordability issues for patients |
4.3.2 Competition from alternative therapies and generic drugs |
4.3.3 Potential side effects and safety concerns associated with imatinib treatment |
5 Sweden Imatinib Drug Market Trends |
6 Sweden Imatinib Drug Market, By Types |
6.1 Sweden Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Sweden Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Sweden Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Sweden Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Sweden Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Sweden Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Sweden Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Sweden Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Sweden Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Sweden Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Sweden Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Sweden Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Sweden Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Sweden Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Sweden Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Sweden Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Sweden Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Sweden Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Sweden Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Sweden Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Sweden Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Sweden Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Sweden Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Sweden Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Sweden Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Sweden Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Sweden Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Sweden Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Sweden Imatinib Drug Market Import-Export Trade Statistics |
7.1 Sweden Imatinib Drug Market Export to Major Countries |
7.2 Sweden Imatinib Drug Market Imports from Major Countries |
8 Sweden Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of clinical trials and research studies on imatinib in Sweden |
8.3 Prescription rate of imatinib by healthcare providers |
9 Sweden Imatinib Drug Market - Opportunity Assessment |
9.1 Sweden Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Sweden Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Sweden Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Sweden Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Sweden Imatinib Drug Market - Competitive Landscape |
10.1 Sweden Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Sweden Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here